Mirati Therapeutics
MRTX
#2965
Rank
C$5.70 B
Marketcap
$81.32
Share price
0.00%
Change (1 day)
50.84%
Change (1 year)

EPS for Mirati Therapeutics (MRTX)

EPS in 2023 (TTM): -$17.32

According to Mirati Therapeutics's latest financial reports the company's current EPS (TTM) is -$17.76. In 2022 the company made an earnings per share (EPS) of -$18.26 a decrease over its 2021 EPS that were of -$15.47.

EPS history for Mirati Therapeutics from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$17.32-5.17%
2022-$18.2617.99%
2021-$15.4740.5%
2020-$11.0140.96%
2019-$7.8177.92%
2018-$4.3913.62%
2017-$3.87-33.57%
2016-$5.8210.82%
2015-$5.2516.98%
2014-$4.49-32.19%
2013-$6.6268.77%
2012-$3.92-15.95%
2011-$4.67-81.27%
2010-$24.91-37.19%
2009-$39.66174.53%
2008-$14.45-65.27%
2007-$41.60146.72%
2006-$16.86-58.81%
2005-$40.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$13.19-174.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.08312-99.53% Bahamas